Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J L Gittoes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Medicine (London, England)|April 23, 2010
Primary hyperparathyroidism--is mild disease worth treating?N J L Gittoes, M S Cooper
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
11beta-hydroxysteroid dehydrogenases, cell proliferation and malignancyE H Rabbitt, N J L Gittoes, P M Stewart, et al.
Oncogene|March 19, 2003
Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferationE H Rabbitt, J Ayuk, K Boelaert, et al.
Clinical Endocrinology|June 20, 2002
Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumoursL A Tannahill, T J Visser, C J McCabe, et al.
Clinical Endocrinology|July 15, 2010
Impact of UK National Guidelines based on FRAX®--comparison with current clinical practiceN J Crabtree, N A Bebbington, D M Chapman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
A potential role for PTTG/securin in the developing human fetal brainK Boelaert, L A Tannahill, J N Bulmer, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancerK Boelaert, C J McCabe, L A Tannahill, et al.
Clinical Endocrinology|February 13, 2003
Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviourC J McCabe, J S Khaira, K Boelaert, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumorsC J McCabe, K Boelaert, L A Tannahill, et al.
Journal of Molecular Endocrinology|December 14, 2004
PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitroK Boelaert, R Yu, L A Tannahill, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Medicine (London, England)|April 23, 2010
Primary hyperparathyroidism--is mild disease worth treating?N J L Gittoes, M S Cooper
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
11beta-hydroxysteroid dehydrogenases, cell proliferation and malignancyE H Rabbitt, N J L Gittoes, P M Stewart, et al.
Oncogene|March 19, 2003
Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferationE H Rabbitt, J Ayuk, K Boelaert, et al.
Clinical Endocrinology|June 20, 2002
Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumoursL A Tannahill, T J Visser, C J McCabe, et al.
Clinical Endocrinology|July 15, 2010
Impact of UK National Guidelines based on FRAX®--comparison with current clinical practiceN J Crabtree, N A Bebbington, D M Chapman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
A potential role for PTTG/securin in the developing human fetal brainK Boelaert, L A Tannahill, J N Bulmer, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancerK Boelaert, C J McCabe, L A Tannahill, et al.
Clinical Endocrinology|February 13, 2003
Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviourC J McCabe, J S Khaira, K Boelaert, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumorsC J McCabe, K Boelaert, L A Tannahill, et al.
Journal of Molecular Endocrinology|December 14, 2004
PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitroK Boelaert, R Yu, L A Tannahill, et al.
Pageof 1